BIOGEN INC. 10-Q filing
Filed 2025-10-30 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0000875045-25-000049
- Form type
- 10-Q
- CIK
- 0000875045
- Primary document
- https://www.sec.gov/Archives/edgar/data/875045/000087504525000049/biib-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOGEN INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $7.6B | - | - |
| Cost Of Revenue | $1.9B | - | - |
| Net Income | $1.3B | - | - |
| Eps Basic | 9.16 | - | - |
| Eps Diluted | 9.14 | - | - |
| Total Assets | $29.2B | - | - |
| Total Liabilities | $11.0B | - | - |
| Operating Cash Flow | $1.7B | - | - |
| Capital Expenditures | $109.9M | - | - |